Search & Analyze

Dr. Reddy's Laboratories Ltd.

HealthcarePharmaceuticals & Drugs

www.drreddys.com BSE: 500124NSE: DRREDDY

₹1,224.50BSE1.17%

23 Oct, 4:01 PM

₹1,224.50

₹1.02L Cr

36.50

2.68

11.69%

₹1,251.00

₹1,215.35

₹1,414.40

₹1,080.05

Customise metrics bar

Dr. Reddy's Laboratories Ltd. (DRREDDY) share price closed at ₹1,224.50 on the BSE on Friday, October 23, 2026, down by 1.17% from its of ₹1,239.00. In that session DRREDDY reached a of 1,251.00 and of 1,215.35. The for the session was 1,229.83. The stands at 1,192.55 and is at 1,243.17. Looking at , the stock ended the session in Downtrend.

Stock Overview

Symbol

DRREDDY

₹1,234.70

₹1,239.00

₹1,229.83

₹1,192.55

Price 2.68% above

₹1,243.17

Price 1.50% below

25.67% of range

₹1,215.35₹1,251.00

43.20% of range

₹1,080.05₹1,414.40

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,743.00	34.58	4,18,204.09	0.92	2,901.23	26.53%	15,299.88	10.46%	19.11
DIVI'S LAB. DIVISLAB	8,984.00	81.54	2,38,496.97	0.33	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,482.00	80.26	1,70,480.87	0.85	534.00	-9.64%	4,979.00	50.79%	19.27
ZYDUSLIFE ZYDUSLIFE	1,127.85	24.93	1,12,503.47	0.09	990.20	-34.90%	8,017.00	21.96%	21.39
CIPLA LTD. CIPLA	1,337.00	32.04	1,08,012.30	0.97	785.55	-39.18%	7,119.28	2.33%	16.00
LAURUSLABS LAURUSLABS	1,974.00	97.55	1,06,657.63	0.10	362.07	123.94%	2,026.31	29.10%	18.20
Dr. Reddy's Laboratories Ltd. DRREDDY	1,224.50	36.50	1,02,206.60	0.65	913.20	-31.69%	8,697.80	-1.48%	13.75
MANKIND MANKIND	2,217.00	44.83	91,572.10	0.05	574.09	29.12%	4,030.59	12.89%	13.24

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	7,113.80	7,696.10	8,038.20	8,381.20	8,528.40	8,572.10	8,828.30	8,753.40	7,546.40	8,099.80	8,697.80
Expenses	5,282.60	5,566.20	5,961.70	6,108.20	6,530.50	6,398.50	6,818.40	6,865.90	7,163.90	7,239.90	6,967.20
	1,831.20	2,129.90	2,076.50	2,273.00	1,997.90	2,173.60	2,009.90	1,887.50	382.50	859.90	1,730.60
	25.74%	27.68%	25.83%	27.12%	23.43%	25.36%	22.77%	21.56%	5.07%	10.62%	19.90%
	197.50	187.20	307.50	150.20	522.10	290.30	323.90	268.80	475.40	354.70	156.20
Interest	59.30	59.80	75.70	81.70	65.60	83.00	90.70	94.40	105.70	125.50	124.80
	367.70	380.60	397.00	471.40	454.70	476.10	504.60	521.00	557.10	536.60	526.70
	1,605.20	1,882.60	1,917.40	1,874.30	2,005.20	1,905.00	1,744.80	1,543.20	199.70	553.30	1,227.60
	18.40%	26.04%	30.01%	25.08%	20.87%	25.99%	23.38%	22.91%	-10.82%	21.27%	25.61%
	1,309.80	1,392.40	1,255.70	1,413.70	1,593.30	1,418.10	1,347.10	1,209.90	220.90	444.30	924.80
	78.53	83.48	75.28	16.95	19.10	16.98	16.13	14.49	2.65	5.32	11.08

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	21,545.20	24,669.70	28,011.10	32,643.90	33,700.20
	21,545.20	24,669.70	28,011.10	32,643.90	33,700.20
EXPENDITURE :
Increase/Decrease in Stock	-353.90	70.90	-680.50	-544.70	-423.60
Raw Material Consumed	7,796.10	7,586.80	8,889.20	10,524.60	12,662.80
Power & Fuel Cost	390.50	477.40	533.90	562.50	556.50
Employee Cost	3,885.80	4,646.60	5,030.10	5,580.00	5,990.90
Other Manufacturing Expenses	1,602.20	1,738.60	2,087.20	2,563.20	2,242.70
General and Administration Expenses	1,547.60	1,497.50	1,848.20	2,173.20	2,084.40
Selling and Distribution Expenses	1,919.20	1,989.40	2,248.20	2,925.50	3,597.50
Miscellaneous Expenses	990.30	313.50	121.70	312.50	535.50
	17,777.80	18,320.70	20,078.00	24,096.80	27,246.70
Operating Profit (Excl OI)	3,767.40	6,349.00	7,933.10	8,547.10	6,453.50
	484.70	1,055.50	894.30	1,097.30	1,358.40
	4,252.10	7,404.50	8,827.40	9,644.40	7,811.90
Interest	95.80	142.80	171.10	282.90	373.80
PBDT	4,156.30	7,261.70	8,656.30	9,361.50	7,438.10
	1,165.20	1,250.20	1,470.00	1,703.70	2,058.80
Profit Before Taxation & Exceptional Items	2,991.10	6,011.50	7,186.30	7,657.80	5,379.30
	3,061.40	6,048.50	7,201.00	7,679.50	5,392.70
Provision for Tax	878.90	1,541.20	1,623.10	1,954.30	1,235.10
	2,182.50	4,507.30	5,577.90	5,725.20	4,157.60
Extra items				0.00	0.00
Minority Interest				-70.10	38.40
Consolidated Net Profit	2,182.50	4,507.30	5,577.90	5,655.10	4,196.00
Profit Balance B/F	14,239.50	16,034.10	20,022.80	24,998.00	30,052.20
Appropriations	16,422.00	20,541.40	25,600.70	30,653.10	34,248.20
Equity Dividend %	600.00%	800.00%	800.00%	800.00%	800.00%
	131.16	270.55	334.41	67.81	50.25
Adjusted EPS	26.23	54.11	66.88	67.81	50.25

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	83.20	83.30	83.40	83.40	83.50
Share Warrants & Outstandings	143.30	145.70	131.30	144.70	148.90
Total Reserves	18,985.90	23,057.10	28,040.10	33,321.50	37,659.10
Reserve excluding Revaluation Reserve	18,985.90	23,057.10	28,040.10	33,321.50	37,659.10
	19,212.40	23,286.10	28,254.80	33,549.60	37,891.50
Minority Interest				377.80	339.40
Secured Loans	194.60	127.80	219.00	406.40	1,220.30
Unsecured Loans	380.00		380.00	380.00
Deferred Tax Assets / Liabilities	-1,275.60	-629.20	-973.70	-428.70	-672.30
Other Long Term Liabilities	166.90	203.20	314.00	245.40	344.30
Long Term Provisions	25.80	19.90	23.90	29.80	33.80
Total Non-Current Liabilities	-508.30	-278.30	-36.80	632.90	926.10
Trade Payables	2,266.20	2,268.40	2,614.40	2,647.80	3,037.90
Other Current Liabilities	3,660.60	4,697.90	4,775.20	5,503.10	6,490.60
Short Term Borrowings	2,708.20	739.00	1,272.30	3,804.50	5,913.60
Short Term Provisions	1,130.80	866.80	926.10	1,078.40	1,305.30
Total Current Liabilities	9,765.80	8,572.10	9,588.00	13,033.80	16,747.40
Total Liabilities	28,469.90	31,579.90	37,806.00	47,594.10	55,904.40
Gross Block	23,096.40	25,567.10	24,527.40	36,759.60	43,854.30
Less: Accumulated Depreciation	14,894.90	16,348.00	14,101.30	18,533.20	21,494.10
Less: Impairment of Assets	80.00		0.50		296.90
Net Block	8,121.50	9,219.10	10,425.60	18,226.40	22,063.30
Capital Work in Progress	1,279.60	975.20	1,351.00	2,399.40	1,460.20
Non Current Investments	593.00	536.30	525.50	720.50	1,612.00
Long Term Investment	593.00	536.30	525.50	720.50	1,612.00
Long Term Loans & Advances	451.70	355.90	541.80	341.40	506.60
Other Non Current Assets	222.40	13.10	88.50	822.20	233.50
Total Non-Current Assets	10,682.00	11,154.50	13,000.70	22,576.10	25,875.60
Currents Investments	2,022.90	4,449.50	4,405.00	3,330.60	3,672.80
Inventories	5,088.40	4,867.00	6,355.20	7,108.50	7,653.40
Sundry Debtors	6,676.40	7,248.50	8,029.80	9,042.00	10,123.40
Cash and Bank	2,419.20	1,730.20	1,727.70	2,460.20	3,348.70
Other Current Assets	736.90	1,203.50	1,011.30	1,072.40	1,183.40
Short Term Loans and Advances	844.10	926.70	3,276.30	2,004.30	4,047.10
Total Current Assets	17,787.90	20,425.40	24,805.30	25,018.00	30,028.80
Net Current Assets (Including Current Investments)	8,022.10	11,853.30	15,217.30	11,984.20	13,281.40
Total Assets	28,469.90	31,579.90	37,806.00	47,594.10	55,904.40
Contingent Liabilities	107.60	107.20	109.10	83.04	336.14
Total Debt	3,384.50	1,347.20	2,002.00	4,676.60	7,734.10
	1,145.98	1,388.98	1,686.06	400.54	452.01
Adjusted Book Value	229.20	277.80	337.21	400.54	452.01

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	3,061.40	6,048.50	7,201.00	7,679.50	5,392.70
Adjustment	2,333.80	1,695.90	1,365.20	1,961.50	2,708.20
Changes In working Capital	-1,840.70	-785.50	-2,018.20	-2,998.90	-1,074.60
Cash Flow after changes in Working Capital	3,554.50	6,958.90	6,548.00	6,642.10	7,026.30
Cash Flow from Operating Activities	2,810.80	5,887.50	4,543.30	4,642.80	5,673.70
Cash Flow from Investing Activities	-2,638.70	-4,137.30	-4,028.30	-5,807.70	-6,549.30
Cash Flow from Financing Activitie	-242.20	-2,686.10	-376.30	1,891.10	829.00
Net Cash Inflow / Outflow	-70.10	-935.90	138.70	726.20	-46.60
Opening Cash & Cash Equivalents	1,482.00	1,485.20	577.90	710.70	1,459.30
Effect of Foreign Exchange Fluctuations	73.30	28.60	-5.90	22.40	124.10
Closing Cash & Cash Equivalent	1,485.20	577.90	710.70	1,459.30	1,536.80

Ratios

Valuation

36.50

2.68

17.08

3.17

33.54

457.39

Profitability

11.69

13.75

8.03

19.15

12.34

Leverage & Liquidity

0.20

1.79

15.43

Returns

0.65

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	26.65	26.64	26.64	26.64	26.64	26.64	26.64	26.63	26.64	26.63
	48.41	49.01	49.74	51.37	52.07	52.67	52.78	51.86	52.40	52.18
	10.36	10.13	10.38	10.44	10.26	9.86	9.71	9.57	9.55	10.08
	58.76	59.14	60.12	61.82	62.32	62.53	62.49	61.43	61.95	62.26
No. of Shareholders	2,67,694	3,10,403	4,03,669	4,59,605	4,51,929	4,49,216	4,55,243	4,49,665	4,46,086	4,76,681

Mutual Funds Invested(287)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 135 active funds hold 11.54% in Dr. Reddy's Laboratories Ltd., contributing to ₹11.88K Cr of holdings

Fund				As of
PP Parag Parikh Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	1,782.68	1.23	1,44,58,054	Sep '26
SB SBI Nifty 50 ETFIndex	1,458.51	0.72	1,18,28,947	Sep '26
IP ICICI Prudential Value Fund - Growth - Direct PlanEquity - Value Fund	1,179.91	2.06	95,69,430	Sep '26
IP ICICI Prudential India Opportunities Fund - Growth - Direct PlanEquity - Thematic Fund - Other	967.25	2.65	78,44,672	Sep '26
IP ICICI Prudential Large Cap Fund - Growth - Direct PlanLarge Cap Fund	779.19	1.02	63,19,449	Sep '26
IP ICICI Prudential Healthcare Fund - Growth - Direct PlanPharma & Health Care	667.57	9.73	54,14,201	Sep '26
UT UTI Nifty 50 ETFIndex	500.19	0.72	40,56,687	Sep '26
NI Nippon India Pharma Fund - Growth - Direct PlanPharma & Health Care	499.33	5.45	40,49,746	Sep '26
NI Nippon India Large Cap Fund - Growth - Direct PlanLarge Cap Fund	493.44	0.96	40,01,922	Sep '26
NI Nippon India ETF Nifty 50 BeESIndex	468.23	0.72	37,97,469	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-09-22	Board Meeting	Quarterly Results
2026-06-30	AGM
2026-06-22	Board Meeting	Quarterly Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)
2026-06-23	Tricia Wetzel	ESOP	Buy	4,275

Sector Overview

HealthcarePharmaceuticals & Drugs

Dr. Reddy's Laboratories Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

14 members across the board and senior leadership

K Randhir Singh

Company Secretary, Compliance Officer and Head-CSR

—

K Satish Reddy

Chairman

₹1.01 Cr

Mar '26

GV Prasad

Co-Chairman & Managing Director

₹1.58 Cr

Mar '26

GV Prasad

Co-Chairman & Managing Director

₹18.83 Cr

Mar '25

Leo Puri

Lead Independent Director

₹22.62 L

Mar '26

Arun Kumar